Life‐threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2003-01, Vol.42 (1), p.193-194
Main Authors: Marchesoni, A., Arreghini, M., Panni, B., Battafarano, N., Uziel, L.
Format: Article
Language:English
Subjects:
Aged
Anti-Inflammatory Agents - therapeutic use
Antibodies, Monoclonal - adverse effects
Antirheumatic Agents - adverse effects
Arthritis, Rheumatoid - drug therapy
Drug Therapy, Combination
Humans
Infliximab
Isoxazoles - adverse effects
Leflunomide
Male
Methotrexate - therapeutic use
Pancytopenia - chemically induced
Steroids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/key051